Juvaris forms acute myelogenous leukemia collaboration with Penn State.(Juvaris BioTherapeutics Inc., Pennsylvania State University): An article from: BIOTECH Patent News
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on September 1, 2004. The length of the article is 520 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Juvaris forms acute myelogenous leukemia collaboration with Penn State.(Juvaris BioTherapeutics Inc., Pennsylvania State University)
Publication: BIOTECH Patent News (Newsletter)
Date: September 1, 2004
Publisher: Biotech Patent News
Volume: 18 Issue: 9
Distributed by Thomson Gale
List Price: $ 5.95
Price: $ 5.95
Leukemia — Comprehensive overview covers symptoms, causes, risk factors, treatment of this blood-related cancer.
Juvaris forms acute myelogenous leukemia collaboration with Penn State.(Juvaris BioTherapeutics Inc., Pennsylvania State University): An article from: BIOTECH Patent News
More Forms Of Leukemia Products
Orignal From: Juvaris forms acute myelogenous leukemia collaboration with Penn State.(Juvaris BioTherapeutics Inc., Pennsylvania State University): An article from: BIOTECH Patent News
No comments:
Post a Comment